TuHURA BIOSCIENCES, INC./NV Payments of Merger Related Costs, Financing Activities
TuHURA BIOSCIENCES, INC./NV (HURA) reported Payments of Merger Related Costs, Financing Activities of $500.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities · last filed 2026-08-14
- TuHURA BIOSCIENCES, INC./NV payments of merger related costs, financing activities for the quarter ending 2025-12-31 was $0.00.
- TuHURA BIOSCIENCES, INC./NV payments of merger related costs, financing activities for the quarter ending 2025-09-30 was $0.00.
- TuHURA BIOSCIENCES, INC./NV payments of merger related costs, financing activities for the quarter ending 2025-06-30 was $0.00.
- TuHURA BIOSCIENCES, INC./NV payments of merger related costs, financing activities for the quarter ending 2025-03-31 was $500.00K.
- TuHURA BIOSCIENCES, INC./NV payments of merger related costs, financing activities for fiscal 2025 was $500.00K, a 86.22% decline from fiscal 2024.
- TuHURA BIOSCIENCES, INC./NV payments of merger related costs, financing activities for fiscal 2024 was $3.63M.
| Period end | Payments of Merger Related Costs, Financing Activities 3 month | Payments of Merger Related Costs, Financing Activities 6 month | Payments of Merger Related Costs, Financing Activities 9 month | Payments of Merger Related Costs, Financing Activities 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $0.00 derived: sum of 3 quarters · filed 2026-08-14 | $500.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2026-08-14 | $500.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $500.00K 10-Q · filed 2026-08-14 | ||
| 2025-03-31 | $500.00K 10-Q · filed 2026-05-15 | |||
| 2024-12-31 | $3.63M 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |